Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design. | MAbs | 2025 | 41058481 | PubTator, text mining | PubMed |
| Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia. | Sci Rep | 2025 | 41006384 | PubTator, text mining | PubMed |
| NCAPH-YAP1 interaction promotes breast cancer stemness and tumor progression. | Stem Cell Res Ther | 2025 | 40999529 | PubTator, text mining | PubMed |
| Discovery of a potent ROR1 inhibitor using μs-scale MD simulations, wt-metadynamics, and absolute binding free energy calculations. | J Mol Model | 2025 | 40996455 | PubTator, text mining | PubMed |
| Profilin and Non-Canonical Wnt Signaling: Coordinating Cytoskeletal Dynamics from Development to Disease. | J Dev Biol | 2025 | 40981267 | PubTator, text mining | PubMed |
| Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers. | Med Sci (Basel) | 2025 | 40981188 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer. | Cancer Med | 2025 | 40970572 | PubTator, text mining | PubMed |
| Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors. | Front Oncol | 2025 | 40969260 | PubTator, text mining | PubMed |
| Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies. | Int J Mol Sci | 2025 | 40943662 | PubTator, text mining | PubMed |
| Immunometabolism: The role of gut-derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy. | Clin Transl Med | 2025 | 40910376 | PubTator, text mining | PubMed |
| Development of Novel Peptide-Based 68Ga-Labeled Radiotracers for Detecting ROR1 Expression in Tumors. | Mol Pharm | 2025 | 40899351 | PubTator, text mining | PubMed |
| Recent advances in universal chimeric antigen receptor T cell therapy. | J Hematol Oncol | 2025 | 40883768 | PubTator, text mining | PubMed |
| Wnt signaling - using the bloodstream to send a message. | Cell Mol Life Sci | 2025 | 40879783 | PubTator, text mining | PubMed |
| The Role of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Cancer Stem Cell Signaling. | Int J Mol Sci | 2025 | 40869147 | PubTator, text mining | PubMed |
| Unveiling CTRB2, RSPO3, KLOTB, and ROR1 as obesity-pancreatic disease association proteins: a comprehensive Mendelian randomization study. | Gastroenterol Rep (Oxf) | 2025 | 40860620 | PubTator, text mining | PubMed |
| Widespread Proteomic Changes Observed in a Cohort of Neonates and Infants Undergoing Cardiopulmonary Bypass. | JACC Adv | 2025 | 40839908 | PubTator, text mining | PubMed |
| The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma. | Hum Cell | 2025 | 40824335 | PubTator, text mining | PubMed |
| Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance. | J Ovarian Res | 2025 | 40813689 | PubTator, text mining | PubMed |
| Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk. | Alzheimers Dement | 2025 | 40810263 | PubTator, text mining | PubMed |
| Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review. | Eur J Med Res | 2025 | 40804731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=5